Related Articles
Molecular and cellular mechanisms of castration resistant prostate cancer (Review)
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer
Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor Corrigendum in /10.3892/ijo.2016.3344
Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells